Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-11-30Clinical Trial Update: Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3 [NA]
This trial investigates the effectiveness of fosinopril and/or losartan in patients with chronic kidney disease, specifically stage 3. The s…
-
CLINICAL_TRIALS research · 2007-11-28Clinical Trial Update: Collection of Blood and Urine Specimens From Volunteers Utilizing Health Examination Services
A clinical trial update from National Taiwan University Hospital describes collecting blood and urine specimens from volunteers using health…
-
CLINICAL_TRIALS trial_result · 2007-11-19Clinical Trial Update: Nutrient Levels Alter Transplant Outcome [NA]
A completed clinical trial at the University of Cincinnati studied how nutrient levels affect transplant outcomes in patients with chronic k…
-
CLINICAL_TRIALS trial_result · 2007-11-12Clinical Trial Update: Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy [Phase 2, Phase 3]
Phase 2/3 trial evaluating the efficacy of N-Acetylcysteine for overt diabetic nephropathy has completed.
-
FDA approval · 2007-11-08FDA Approved: ARANESP — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for ARANESP (darbepoetin alfa) from Amgen, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
A clinical trial evaluating klotho gene polymorphism in dialysis patients with hyperphosphatemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography [Phase 4]
Phase 4 clinical trial comparing two iodinated contrast media in patients at risk undergoing coronary angiography to evaluate renal effects;…
-
EMA guidance · 2007-10-23Public Statement: Epoetins and the risk of tumour growth progression and thromboembolic events in cancer patients and cardiovascular risks in patients with chronic kidney disease
EMA public statement warning about risks associated with epoetins, including tumor progression, thromboembolic events in cancer patients, an…
-
FDA approval · 2007-10-19FDA Approved: SEVELAMER CARBONATE — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved SEVELAMER CARBONATE (Sanofi-Aventis U.S. LLC) for control of serum phosphate in adults with chronic kidney disease on dialysis.
-
FDA label_change · 2007-10-19FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer hydrochloride, updating the labeling for the product.
-
CLINICAL_TRIALS trial_result · 2007-10-18Clinical Trial Update: Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease [Phase 4]
A Phase 4 clinical trial evaluating a carbonaceous oral adsorbent for slowing progression of chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2007-10-05Clinical Trial Update: A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis [Phase 2]
A Phase 2 clinical trial evaluating the safety of PEG-Hirudin (SPP200) versus heparin in patients on haemodialysis has completed.
-
CLINICAL_TRIALS research · 2007-10-04Clinical Trial Update: NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels [NA]
This document provides an update on the NEPHRODIAB2 trial, a prospective randomized study in chronic kidney disease comparing two hemoglobin…
-
CLINICAL_TRIALS trial_result · 2007-09-26Clinical Trial Update: Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis [Phase 4]
A Phase 4 trial comparing initial dosing parameters for Zemplar (paricalcitol) in stage V chronic kidney disease patients on hemodialysis ha…
-
CLINICAL_TRIALS research · 2007-09-20Clinical Trial Update: N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure [Phase 2, Phase 3]
Clinical trial update describing Phase 2/Phase 3 evaluation of N-acetylcysteine in patients with heart failure and coexisting chronic kidney…
-
CLINICAL_TRIALS trial_result · 2007-09-12Clinical Trial Update: Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System [NA]
A completed clinical trial evaluating optimization of nephroprotection with renin-angiotensin-aldosterone system inhibitors in chronic kidne…
-
CLINICAL_TRIALS trial_result · 2007-08-24Clinical Trial Update: Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention [Phase 2, Phase 3]
Iloprost was evaluated for prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography or PCI. The clin…
-
FDA approval · 2007-08-14FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer hydrochloride (Renagel) filed by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS research · 2007-08-14Clinical Trial Update: Relationship of Peritoneal Solute Transport Rate With VEGF in Children Undergoing Peritoneal Dialysis
Clinical trial update examining whether peritoneal solute transport rate is related to VEGF in children undergoing peritoneal dialysis.
-
FDA label_change · 2007-07-17FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for ZEMPLAR (paricalcitol) from AbbVie, resulting in changes to the product labeling. Paricalcitol i…
-
CLINICAL_TRIALS trial_result · 2007-06-19Clinical Trial Update: Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD [Phase 4]
A Phase 4 trial investigated the roles of Sevelamer and Fetuin-A in endothelial dysfunction associated with chronic kidney disease. The stud…
-
CLINICAL_TRIALS trial_result · 2007-05-15Clinical Trial Update: Sodium-Endothelial Function-CKD Study [NA]
This clinical trial update notes the completion of a study investigating sodium-related endothelial function in chronic kidney disease.
-
CLINICAL_TRIALS research · 2007-05-15Clinical Trial Update: Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA) [Phase 4]
Phase 4 clinical trial update evaluating mycophenolate mofetil–based immunosuppressive regimens to optimize renal function in kidney transpl…
-
CLINICAL_TRIALS trial_result · 2007-05-14Clinical Trial Update: Haemodialysis Salt Reduction Study [NA]
This update reports the completion of a haemodialysis salt reduction clinical trial conducted by St George's, University of London, involvin…
-
CLINICAL_TRIALS trial_result · 2007-05-10Clinical Trial Update: Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients [EARLY_Phase 1]
Early-phase 1 trial evaluating the immunoregulatory effects of immunoglobulin induction therapy in renal transplant recipients has completed…